Intro

PetXmarkTM

PetXmarkTM is indicated for use to radiographically mark subcutaneous tissue in dogs and cats.

PetXmarkTM is a sterile liquid in a 1 mL glass ampoule. It can be injected using thin needles up to 25G. Upon injection into soft tissue, a radiopaque, sticky and gel-like fiducial marker is formed. The markers are visible on X-ray (kV, CT, CBCT).

PetXmarkTM enables high precision in Image-Guided Radiation Therapy (IGRT).

Cancer in pets

According to The Veterinary Cancer Society, anĀ estimated 6 million dogs are diagnosed with cancer in the US every year. Cancer is the leading cause of death in 47% of dogs, especially dogs over age ten, and 32% of cats.

There are nearly 100 types of animal cancer. Cancer in pets can be found in the skin, bones, breast, head & neck, lymph system, abdomen and testicles. Approximately one-third of all tumors in dogs are skin tumors, and up to twenty percent of those are mast cell tumors. The most common location to find mast cell tumors is in the skin, followed by the spleen, liver, and bone marrow.

Approximately half of all skin tumors are found on the body, other forty percent on the limbs (most frequently the hind limbs), and the remainder on the head or neck.